Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Meraviglia-Crivelli

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
Molecular Cancer|November 29, 2022
IL-6/STAT3 signaling in tumor cells restricts the expression of frameshift-derived neoantigens by SMG1 inductionDaniel Meraviglia-Crivelli, Helena Villanueva, Angelina Zheleva, et al.
Molecular Therapy. Nucleic Acids|May 15, 2024
CD3 aptamers promote expansion and persistence of tumor-reactive T cells for adoptive T cell therapy in cancerAshwathi Puravankara Menon, Helena Villanueva, Daniel Meraviglia-Crivelli, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
Molecular Cancer|November 29, 2022
IL-6/STAT3 signaling in tumor cells restricts the expression of frameshift-derived neoantigens by SMG1 inductionDaniel Meraviglia-Crivelli, Helena Villanueva, Angelina Zheleva, et al.
Molecular Therapy. Nucleic Acids|May 15, 2024
CD3 aptamers promote expansion and persistence of tumor-reactive T cells for adoptive T cell therapy in cancerAshwathi Puravankara Menon, Helena Villanueva, Daniel Meraviglia-Crivelli, et al.
Pageof 2